These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18445043)

  • 1. Mixed-lineage eosinophil/basophil crisis in MDS: a rare form of progression.
    Wimazal F; Baumgartner C; Sonneck K; Zauner C; Geissler P; Schur S; Samorapoompichit P; Müllauer L; Födinger M; Agis H; Sperr WR; Valent P
    Eur J Clin Invest; 2008 Jun; 38(6):447-55. PubMed ID: 18445043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the prognostic significance of eosinophilia and basophilia in a larger cohort of patients with myelodysplastic syndromes.
    Wimazal F; Germing U; Kundi M; Noesslinger T; Blum S; Geissler P; Baumgartner C; Pfeilstoecker M; Valent P; Sperr WR
    Cancer; 2010 May; 116(10):2372-81. PubMed ID: 20209617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on human basophil and eosinophil colonies in human blood mononuclear cell culture: presence of common basophil-eosinophil progenitors].
    Musashi M
    Hokkaido Igaku Zasshi; 1989 Sep; 64(5):567-79. PubMed ID: 2480321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus.
    Lourenço FD; Azor MH; Santos JC; Prearo E; Maruta CW; Rivitti EA; Duarte AJ; Sato MN
    Br J Dermatol; 2008 May; 158(5):979-86. PubMed ID: 18341658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation.
    Puccetti A; Bason C; Simeoni S; Millo E; Tinazzi E; Beri R; Peterlana D; Zanoni G; Senna G; Corrocher R; Lunardi C
    Clin Exp Allergy; 2005 Dec; 35(12):1599-607. PubMed ID: 16393326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myelodysplastic syndrome associated with marked eosinophilia and basophilia].
    Tanabe J; Sasaki S; Tamura T; Okamoto R; Sugamura R; Fujita H; Fukawa H; Kanamori H; Matsuzaki M; Mohri H
    Rinsho Ketsueki; 1992 Feb; 33(2):189-93. PubMed ID: 1635167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
    Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungolino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G;
    Haematologica; 2008 Dec; 93(12):1792-6. PubMed ID: 18838477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical biological features of mixed myeloid diseases].
    Gritsaev SV; Abldulkadyrov KM; Tiranova SA; Kapustin SI; Martynkevich IS; Bessmel'tsev SS; Rugal' VI; Bakaĭ MP
    Ter Arkh; 2004; 76(12):68-73. PubMed ID: 15724931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
    Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
    Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.
    Valent P
    Blood Rev; 2009 Jul; 23(4):157-65. PubMed ID: 19246139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm.
    Tang G; Woods LJ; Wang SA; Brettler D; Andersen M; Miron PM; Pechet L; Woda BA; Hao S
    Hum Pathol; 2009 Aug; 40(8):1194-9. PubMed ID: 19427022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative, phenotypic, and functional evaluation of basophils in myelodysplastic syndromes.
    Füreder W; Schernthaner GH; Ghannadan M; Hauswirth A; Sperr WR; Semper H; Majlesi Y; Zwirner J; Götze O; Bühring HJ; Lechner K; Valent P
    Eur J Clin Invest; 2001 Oct; 31(10):894-901. PubMed ID: 11737228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
    Kim DH; Popradi G; Sriharsha L; Kamel-Reid S; Chang H; Messner HA; Lipton JH
    Cancer; 2008 Aug; 113(4):772-81. PubMed ID: 18543309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
    Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
    Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes.
    Bacher U; Haferlach T; Kern W; Weiss T; Schnittger S; Haferlach C
    Cancer; 2009 Oct; 115(19):4524-32. PubMed ID: 19569249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric detection of degranulated basophils in chronic myeloid leukemia in accelerated phase.
    Stacchini A; Demurtas A; Godio L
    Cytometry B Clin Cytom; 2011 Mar; 80(2):122-4. PubMed ID: 20845367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilia-associated muscle disorders: an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms.
    Cantarini L; Volpi N; Carbotti P; Greco G; Aglianò M; Bellisai F; Giannini F; Alessandrini C; Grasso G; Galeazzi M
    J Clin Pathol; 2009 May; 62(5):442-7. PubMed ID: 19139036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis.
    Berger D; Bauer K; Kornauth C; Gamperl S; Stefanzl G; Smiljkovic D; Sillaber C; Bettelheim P; Knöbl P; Schiefer AI; Greiner G; Thalhammer R; Hoermann G; Schwarzinger I; Staber PB; Sperr WR; Valent P
    Neoplasia; 2021 Dec; 23(12):1183-1191. PubMed ID: 34731787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation.
    Boehm A; Sperr WR; Leitner G; Worel N; Oehler L; Jaeger E; Mitterbauer M; Haas OA; Valent P; Kalhs P; Rabitsch W
    Eur J Clin Invest; 2008 Dec; 38(12):945-52. PubMed ID: 19021720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the peripheral eosinophil count in patients with acute eosinophilic myocarditis.
    Morimoto S; Kubo N; Hiramitsu S; Uemura A; Ohtsuki M; Kato S; Kato Y; Sugiura A; Miyagishima K; Mori N; Yoshida Y; Hishida H
    Heart Vessels; 2003 Sep; 18(4):193-6. PubMed ID: 14520487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.